Latest 30 News in the Life Sciences Industry
PR Newswire Association LLC.
Keikku and ACEP Sign Collaboration Agreement to Bring Emergency Medicine Guidelines into Contextual Clinical Decision Support
12 Nov 2026
PR Newswire Association LLC.
Werfen launches a campaign to thank healthcare professionals and laboratories as part of its 60-year celebrations
12 Nov 2026
PR Newswire Association LLC.
Roche opens up new possibilities for genomic research in Asia Pacific with next-generation sequencing technology
08 Nov 2026
PR Newswire Association LLC.
Combinations of iOnctura's roginolisib revert immune suppression in immunotherapy-resistant NSCLC
06 Nov 2026
PR Newswire Association LLC.
Harbour BioMed Appoints Ms. Vivian Feng as Head of External Collaboration
05 Nov 2026
PR Newswire Association LLC.
Abbott and Novo expand partnership to launch Plosbrio® broadening access to semaglutide for advanced diabetes care across Asia Pacific
05 Nov 2026
PR Newswire Association LLC.
Anaheim Bio Launches with €40 Million Series A Financing to Advance ANA-1 for Calcium Pyrophosphate Deposition Disease into the Clinic
05 Nov 2026
PR Newswire Association LLC.
SkylineDx Wins 2026 BioTech Breakthrough Award for "Diagnostics Company of the Year" for Second Consecutive Year
05 Nov 2026
PR Newswire Association LLC.
LIPSIA-STRATEGY trial demonstrates non-inferiority of CAAS vFFR guided revascularization against pressure wire-based FFR revascularization
03 Nov 2026
PR Newswire Association LLC.
EASE Secures US$9.5 Million to Expand AI-Enabled Medical Imaging and Surgical Robotics in South Africa and Ghana
02 Nov 2026
PR Newswire Association LLC.
iOnctura to present late-breaking data on roginolisib in immunotherapy-resistant NSCLC at SITC
29 Oct 2026
PR Newswire Association LLC.
Former Philips Latin America CEO Fabia Tetteroo-Bueno Joins Lapsi Health / Keikku Board to Lead Latin American Expansion
29 Oct 2026
PR Newswire Association LLC.
European court grants preliminary injunction against Pendulum and iHerb based on Caelus patent
28 Oct 2026
PR Newswire Association LLC.
At ESMO 2026, Sun Pharma to Present Long-Term Follow-up Data on UNLOXCYT® (cosibelimab-ipdl) from One of the Largest Prospective Studies in Advanced Cutaneous Squamous Cell Carcinoma (aCSCC)
23 Oct 2026
PR Newswire Association LLC.
Harbour BioMed Receives China NMPA Approval of Batoclimab Injection (Subcutaneous Injection) for the Treatment of Generalized Myasthenia Gravis
23 Oct 2026
GlobeNewswire
argenx Announces Commencement of Tender Offer to Acquire Forte Biosciences, Inc.
06 Aug 2026
GlobeNewswire
Avalo Therapeutics Reports Second Quarter 2026 Financial Results and Recent Business Updates
06 Aug 2026
GlobeNewswire
NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
06 Aug 2026
GlobeNewswire
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons
06 Aug 2026
GlobeNewswire
Market launch of the nasal adrenaline spray, neffy®, for treatment of adults and children with severe allergies in Canada
05 Aug 2026
GlobeNewswire
Novo Nordisk wins Dutch court injunction protecting patients from unapproved, unlawful compounded semaglutide nasal spray
05 Aug 2026
GlobeNewswire
NewAmsterdam Pharma Provides Corporate Update and Reports Second Quarter Financial Results
05 Aug 2026
GlobeNewswire
Pharming Group to participate in Canaccord Genuity 46th Annual Growth Conference
04 Aug 2026
GlobeNewswire
Novo Nordisk reports adjusted operating profit of DKK 33,389 million for Q2 2026 and raises full-year outlook
04 Aug 2026
GlobeNewswire
Novo Nordisk raises adjusted sales and adjusted operating profit outlook for 2026
04 Aug 2026
GlobeNewswire
argenx announces Extraordinary General Meeting of Shareholders on September 17, 2026
03 Aug 2026
GlobeNewswire
Novo Nordisk provides update on the ZEUS phase 3 trial in people with ASCVD, CKD and inflammation
31 Jul 2026
Upcoming Events All Events
- November 2026
- London: LSX Investival Showcase London
- Zurich: AutomaPlus 2026
- London: Latest & Future Technologies Impacting Life Sciences
